Cargando…
Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
BACKGROUND: Cardiac amyloidosis (CA), following a non-invasive diagnosis, constitutes an increasingly prevalent heart failure (HF) etiology. This study aims to determine which echocardiography findings help to diagnose CA in patients with left ventricular hypertrophy (LVH) admitted for decompensated...
Autores principales: | Polo, Jorge Melero, Barrenechea, Ana Roteta Unceta, Martí, Pablo Revilla, Palacios, Raquel Pérez, Gutiérrez, Anyuli Gracia, Juana, Esperanza Bueno, Gracia, Alejandro Andrés, Ayala, Saida Atienza, Arregui, Miguel Ángel Aibar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129250/ https://www.ncbi.nlm.nih.gov/pubmed/34355777 http://dx.doi.org/10.5603/CJ.a2021.0085 |
Ejemplares similares
-
Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
por: Moreno-Gázquez, Inmaculada, et al.
Publicado: (2023) -
Failure to Confirm Typical Echocardiographic Findings of Cardiac Amyloidosis in an Unresolved Nonischemic Cardiomyopathy Associated With Smoldering Multiple Myeloma: A Case Report
por: Gaibor, Carlos, et al.
Publicado: (2023) -
Paradoxical Left Ventricular Hypertrophy by Echocardiogram and Low Voltage ECG: A Key Clue in the Diagnostic Workup of Two Distinct Presentations of Cardiac AL Amyloidosis
por: Tolu-Akinnawo, Oluwaremilekun, et al.
Publicado: (2023) -
An Echocardiographic Insight Into Post-COVID-19 Symptoms
por: Flores, Rui, et al.
Publicado: (2023) -
A Late Diagnosis of Transthyretin Amyloidosis
por: Pfirman, Kristopher S, et al.
Publicado: (2022)